Torao Ishida

Prof. Dr. Torao Ishida


Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 October 2012 in Evidence-Based Complementary and Alternative Medicine
Verified
Journal Article
Open access
PDF file
TMToshihiro Miura
Toshihiro Miura
STSatoshi Takagi
Satoshi Takagi
Torao IshidaTorao Ishida
Torao Ishida
Banaba (Lagerstroemia speciosa L.) extracts have been used for many years in folk medicine to treat diabetes, with the first published research study being reported in 1940. This paper summarizes the current literature regarding Banaba and its constituents. The hypoglycemic effects of Banaba have been attributed to both corosolic acid as well as ellagitannins. Studies have been conducted in various animal models, human subjects, and in vitro systems using water soluble Banaba leaf extracts, corosolic acid, and ellagitannins. Corosolic acid has been reported to decrease blood sugar levels within 60 min in human subjects. Corosolic acid also exhibits antihyperlipidemic and antioxidant activities. The beneficial effects of Banaba and corosolic acid with respect to various aspects of glucose and lipid metabolism appear to involve multiple mechanisms, including enhanced cellular uptake of glucose, impaired hydrolysis of sucrose and starches, decreased gluconeogenesis, and the regulation of lipid metabolism. These effects may be mediated by PPAR and other signal transduction factors. Banaba extract, corosolic acid, and other constituents may be beneficial in addressing the symptoms associated with metabolic syndrome, as well as offering other health benefits.

1 April 2016 in Neuroscience Letters
Verified
Journal Article
Closed access
NTNobuyuki Tanahashi
Nobuyuki Tanahashi
KTKen Takagi
Ken Takagi
NANozomi Amagasu
Nozomi Amagasu
GWGuifeng Wang
Guifeng Wang
KMKaito Mizuno
Kaito Mizuno
Torao IshidaTorao Ishida
Torao Ishida

8 December 2016 in Journal of Acupuncture and Meridian Studies
Verified
Journal Article
Open access
PDF file
KTKen Takagi
Ken Takagi
NTNobuyuki Tanahashi
Nobuyuki Tanahashi
NANozomi Amagasu
Nozomi Amagasu
KMKaito Mizuno
Kaito Mizuno
JKJun Kawanokuchi
Jun Kawanokuchi
Torao IshidaTorao Ishida
Torao Ishida
A previous study on rats showed that simultaneous acupuncture stimulation at the “Bai-Hui” (GV 20) and the “Yintáng” (Ex-HN3) acupoints alleviated the state of depression to an extent similar to that achieved by pharmacotherapy. This study investigated whether the alleviation of the depressed state required simultaneous acupuncture at these two acupuncture points. For the purposes of testing the effect of acupuncture on depressive symptoms, we treated a depression model rat, where depression had been induced by using a mild water-immersion stress technique, with either acupuncture stimulation at only one acupuncture point (GV 20 or Ex-HN3) or an antidepressant, and we measured the immobile time for evaluating the state of depression. Anxiety, as a symptom commonly associated with depression, was also evaluated by measuring the number of head dips. Neither the immobile time nor the number of head dips decreased upon acupuncture stimulation. From this study, single acupuncture stimulation at either “GV 20” or “Ex-HN3” alleviated neither the state of depression nor the anxiety. The water-immersion stress used to make the depression model rats was shown not to induce anxiety; however, the stress induced by immobilizing the rats for acupuncture stimulation did lead to anxiety.

1 March 2006 in Chinese Journal of Integrative Medicine
Verified
Journal Article
Closed access
PDF file
ZWZhang Wen-Ping
Zhang Wen-Ping
Torao IshidaTorao Ishida
Torao Ishida

28 August 2023 in Biology
Verified
Journal Article
Open access
PDF file
Torao IshidaTorao Ishida
Torao Ishida
KTKen Takagi
Ken Takagi
Guifeng WangGuifeng Wang
Guifeng Wang
NTNobuyuki Tanahashi
Nobuyuki Tanahashi
JKJun Kawanokuchi
Jun Kawanokuchi
Ning MaNing Ma
Ning Ma
(1) Background: It is our purpose to identify the differences in the changes in Complement C5a receptor 1 (C5aR1) levels showing the degree of inflammation at onset and Immunoglobulin G (IgG) levels showing the extent of survival of the virus fragments after recovery between coronavirus disease 2019 (COVID-19) and pneumonia coronavirus disease (non-COVID-19) for saving patients’ lives. (2) Methods: First, the studies showing these markers’ levels in individual patients before and after the passage of time were selected from the PubMed Central® databases with the keywords (((COVID-19) AND individual) NOT review) AND C5a/IgG. Then, no changes in these markers’ levels with conventional analyses were selected from the studies. Finally, the no changes were reexamined with our new two-tailed t-test using the values on the regression line between initial levels and changed levels instead of the mean or median of changed levels as the expected values of changed levels. (3) Results: Not conventional analyses but our new t-test suggested a greater increase in C5aR1-levels at onset and a smaller decrease in IgG-levels after recovery in COVID-19 patients than non-COVID-19 patients. (4) Conclusion: Our new t-test also should be used in clinics for COVID-19 patients.

1 June 2014 in World Journal of Acupuncture - Moxibustion
Verified
Journal Article
Closed access
GWGui-Feng Wang
Gui-Feng Wang
KTKen Takagi
Ken Takagi
KMKaito Mizuno
Kaito Mizuno
YSYoshinori Sunami
Yoshinori Sunami
YGYi Guo
Yi Guo
Torao IshidaTorao Ishida
Torao Ishida